Matthew Habgood, Cresset’s Principal Computational Chemistry Developer will be at the BMCS 3rd Conformational Design in Drug Discovery 2026. If you’re attending, introduce yourself and explore how Cresset’s expertise could help move your drug discovery projects forward.
